• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间歇性生理盐水冲洗或持续性生理盐水输注:在推荐无肝素透析时哪种效果更好?

Intermittent saline flushes or continuous saline infusion: what works better when heparin-free dialysis is recommended?

作者信息

Zimbudzi Edward

机构信息

Department of Nephrology, Monash Health, Monash Medical Centre, Clayton, Melbourne, VIC, Australia.

出版信息

Int J Nephrol Renovasc Dis. 2013 Apr 15;6:65-9. doi: 10.2147/IJNRD.S43252. Print 2013.

DOI:10.2147/IJNRD.S43252
PMID:23637548
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3634321/
Abstract

INTRODUCTION

Coagulation-free dialysis, also commonly known as "heparin-free" dialysis, can be a challenging procedure as it increases the risk of clotting the dialysis circuit. Utilizing a better saline flushing technique can lead to improved patient outcomes as well as huge financial benefits to the health institution. The purpose of this study was to compare the effectiveness of continuous saline infusion (CSI) and intermittent saline flushing (ISF) in preventing clotting of the dialysis extracorporeal circuit (ECC).

METHODS

Fifty heparin-free treatments were randomized into two treatment arms, namely CSI and ISF. Predialysis full blood count and coagulation studies were performed for all patients. During ISF, 100 mL saline was infused via the arterial line every 30 minutes while occluding the blood inlet line. Normal saline was infused into the ECC at a rate of 200 mL/hour throughout the duration of dialysis under CSI. The ECC was inspected for clotting and graded accordingly post-dialysis.

RESULTS

Seventy-six percent of the CSI treatments were completed without losing the ECC while 52% of the ISF treatments were also successful. Patients who were treated with CSI were less likely to have clotted ECCs (odds ratio 3.4, 95% CI, 1.04 to 11.2; P = 0.04). No significant differences existed between the two groups' hematological factors that could influence clotting, such as hemoglobin and platelets.

CONCLUSION

This study demonstrates that, when heparin-free dialysis is indicated, CSI might be a better method of preventing the ECC from clotting. There is a greater chance of realizing long-term benefits to patients and the health service with the CSI method since there is a likelihood of a reduction in the use of erythropoietin-stimulating agents and blood transfusions with the CSI method.

摘要

引言

无凝血透析,通常也被称为“无肝素”透析,是一个具有挑战性的过程,因为它会增加透析回路凝血的风险。采用更好的生理盐水冲洗技术可以改善患者预后,并为医疗机构带来巨大的经济效益。本研究的目的是比较持续生理盐水输注(CSI)和间歇性生理盐水冲洗(ISF)在预防透析体外循环(ECC)凝血方面的效果。

方法

将50次无肝素治疗随机分为两个治疗组,即CSI组和ISF组。对所有患者进行透析前全血细胞计数和凝血研究。在ISF期间,每隔30分钟通过动脉管路输注100 mL生理盐水,同时阻断血液入口管路。在CSI期间,在整个透析过程中以200 mL/小时的速度将生理盐水输注到ECC中。透析后检查ECC是否凝血并进行相应分级。

结果

76%的CSI治疗在未丢失ECC的情况下完成,而52%的ISF治疗也取得成功。接受CSI治疗的患者ECC发生凝血的可能性较小(优势比3.4,95%置信区间,1.04至11.2;P = 0.04)。两组之间可能影响凝血的血液学因素,如血红蛋白和血小板,没有显著差异。

结论

本研究表明,当需要进行无肝素透析时,CSI可能是预防ECC凝血的更好方法。由于CSI方法有可能减少促红细胞生成素刺激剂的使用和输血,因此使用CSI方法更有可能为患者和医疗服务带来长期益处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b051/3634321/677f97a162a6/ijnrd-6-065f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b051/3634321/677f97a162a6/ijnrd-6-065f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b051/3634321/677f97a162a6/ijnrd-6-065f1.jpg

相似文献

1
Intermittent saline flushes or continuous saline infusion: what works better when heparin-free dialysis is recommended?间歇性生理盐水冲洗或持续性生理盐水输注:在推荐无肝素透析时哪种效果更好?
Int J Nephrol Renovasc Dis. 2013 Apr 15;6:65-9. doi: 10.2147/IJNRD.S43252. Print 2013.
2
Rationale and design of the HepZero study: a prospective, multicenter, international, open, randomized, controlled clinical study with parallel groups comparing heparin-free dialysis with heparin-coated dialysis membrane (Evodial) versus standard care: study protocol for a randomized controlled trial.HepZero 研究的原理和设计:一项前瞻性、多中心、国际性、开放、随机、对照临床试验,采用平行组设计,比较无肝素透析与肝素涂层透析膜(Evodial)与标准治疗的疗效:一项随机对照试验的研究方案。
Trials. 2013 Jun 1;14:163. doi: 10.1186/1745-6215-14-163.
3
Intermittent saline flushes during haemodialysis do not alleviate coagulation and clot formation in stable patients receiving reduced doses of dalteparin.在接受低剂量达肝素治疗的稳定患者中,血液透析期间间歇性生理盐水冲洗并不能缓解凝血和血栓形成。
Nephrol Dial Transplant. 2006 Feb;21(2):444-9. doi: 10.1093/ndt/gfi203. Epub 2005 Oct 18.
4
Vitamin E-Coated and Heparin-Coated Dialyzer Membranes for Heparin-Free Hemodialysis: A Multicenter, Randomized, Crossover Trial.维生素 E 涂层和肝素涂层透析器膜在无肝素血液透析中的应用:一项多中心、随机、交叉试验。
Am J Kidney Dis. 2016 Nov;68(5):752-762. doi: 10.1053/j.ajkd.2016.05.013. Epub 2016 Jun 23.
5
Heparin free dialysis: comparative data and results in high risk patients.无肝素透析:高危患者的比较数据及结果
Kidney Int. 1987 Jun;31(6):1351-5. doi: 10.1038/ki.1987.149.
6
Evaluation of three different methods to prevent dialyzer clotting without causing systemic anticoagulation effect.评估三种不同的方法来防止透析器凝血而不引起全身抗凝作用。
Artif Organs. 2011 Jan;35(1):83-8. doi: 10.1111/j.1525-1594.2010.01038.x.
7
Normal saline (0.9% sodium chloride) versus heparin intermittent flushing for the prevention of occlusion in long-term central venous catheters in infants and children.生理盐水(0.9%氯化钠)与肝素间歇性冲管预防婴幼儿长期中心静脉导管堵塞的比较
Cochrane Database Syst Rev. 2020 Apr 30;4(4):CD010996. doi: 10.1002/14651858.CD010996.pub3.
8
Dialysis circuit clotting in critically ill patients with COVID-19 infection.COVID-19 感染危重症患者的透析回路凝血。
BMC Nephrol. 2021 Apr 20;22(1):141. doi: 10.1186/s12882-021-02357-3.
9
[Prevention of thrombogenesis in the extracorporeal circuit of hemodialysis with a low molecular heparin: standardization of the dosage with a better hemorrhagic risk/effectiveness ratio].[低分子肝素预防血液透析体外循环血栓形成:具有更佳出血风险/有效性比的剂量标准化]
Acta Med Port. 1992 Feb;5(2):65-70.
10
Evaluation with micro-CT of different anticoagulation strategies during hemodialysis in patients with thrombocytopenia: A randomized crossover study.血小板减少症患者血液透析期间不同抗凝策略的微计算机断层扫描评估:一项随机交叉研究。
Artif Organs. 2019 Aug;43(8):756-763. doi: 10.1111/aor.13452. Epub 2019 Apr 7.

引用本文的文献

1
Saline flushing to prevent circuit clotting during CRRT without anticoagulant: a randomized controlled study.无抗凝剂连续性肾脏替代治疗(CRRT)期间生理盐水冲洗预防管路凝血的随机对照研究。
BMC Nurs. 2025 Aug 25;24(1):1109. doi: 10.1186/s12912-025-03762-x.
2
Hemodialysis without Systemic Anticoagulation: A Randomized Controlled Trial to Evaluate Five Strategies in Patients at a High Risk of Bleeding.无全身抗凝的血液透析:一项评估五种策略在高出血风险患者中的随机对照试验。
Med Sci (Basel). 2024 Aug 4;12(3):38. doi: 10.3390/medsci12030038.
3
Extension of Tablo TrEatmeNt Duration (XTEND) study: successful 24 h prolonged therapy with Tablo in critical patients.

本文引用的文献

1
Hemodialysis without heparin: a randomized, controlled, crossover study of two dialysis membranes (AN69ST and polysulfone F60).无肝素血液透析:两种透析膜(AN69ST和聚砜F60)的随机对照交叉研究
Int J Artif Organs. 2011 Dec;34(12):1165-71. doi: 10.5301/ijao.5000033.
2
What are the anticoagulation options for intermittent hemodialysis?间歇性血液透析的抗凝选择有哪些?
Nat Rev Nephrol. 2011 Jul 5;7(9):499-508. doi: 10.1038/nrneph.2011.88.
3
Use of saline flush to prevent filter clotting in continuous renal replacement therapy without anticoagulant.
Tablo 治疗时间延长(XTEND)研究的扩展:Tablo 在危重症患者中成功进行 24 小时延长治疗。
BMC Nephrol. 2022 Oct 21;23(1):338. doi: 10.1186/s12882-022-02968-4.
4
Modified regional citrate anticoagulation is optimal for hemodialysis in patients at high risk of bleeding: a prospective randomized study of three anticoagulation strategies.改良区域性枸橼酸抗凝在高出血风险血液透析患者中效果最佳:三种抗凝策略的前瞻性随机研究。
BMC Nephrol. 2019 Dec 19;20(1):472. doi: 10.1186/s12882-019-1661-y.
5
An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis.间歇性血液透析期间四种低剂量抗凝模式的评估
Eur J Clin Pharmacol. 2018 Mar;74(3):267-274. doi: 10.1007/s00228-017-2389-x. Epub 2017 Dec 2.
J Med Assoc Thai. 2011 Feb;94 Suppl 1:S105-10.
4
Evaluation of three different methods to prevent dialyzer clotting without causing systemic anticoagulation effect.评估三种不同的方法来防止透析器凝血而不引起全身抗凝作用。
Artif Organs. 2011 Jan;35(1):83-8. doi: 10.1111/j.1525-1594.2010.01038.x.
5
Review: anticoagulation for haemodialysis.综述:血液透析中的抗凝。
Nephrology (Carlton). 2010 Jun;15(4):386-92. doi: 10.1111/j.1440-1797.2010.01298.x.
6
Comparative study of anticoagulation versus saline flushes in continuous renal replacement therapy.连续性肾脏替代治疗中抗凝剂与生理盐水冲洗的对比研究
Saudi J Kidney Dis Transpl. 2010 May;21(3):478-83.
7
The CARI guidelines. Biochemical and haematological targets. Haemoglobin.CARI指南。生化和血液学指标。血红蛋白。
Nephrology (Carlton). 2008 Jul;13 Suppl 2:S44-56. doi: 10.1111/j.1440-1797.2008.00997.x.
8
Essentials of anticoagulation in hemodialysis.血液透析中的抗凝要点。
Hemodial Int. 2007 Apr;11(2):178-89. doi: 10.1111/j.1542-4758.2007.00166.x.
9
[Hemoglobin target in hemodialysis patients].
Nephrol Ther. 2006 Sep;2 Suppl 4:S239-44.
10
Anticoagulant-free Genius haemodialysis using low molecular weight heparin-coated circuits.使用低分子量肝素涂层回路的无抗凝剂Genius血液透析
Nephrol Dial Transplant. 2006 Apr;21(4):1013-8. doi: 10.1093/ndt/gfi293. Epub 2005 Dec 2.